In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Viacor Inc.

www.viacorinc.com

Latest From Viacor Inc.

Percutaneous Mitral Valve Therapy: The Next Decade

After more than a decade, the field of transcatheter mitral valve therapy is still in its infancy, yet it is surprisingly crowded. The first percutaneous mitral valve company was founded in 1999, the same year that the first transcatheter aortic valve implantation (TAVI) company was founded, but while TAVI is now on the market in Europe and in the US, the leading transcatheter mitral valve therapy has only just completed clinical trials.

Medical Device Innovation

Medtronic: Doing Just What the Doctors Order

Medtronic has recruited physician opinion leaders for strategic management positions in most of its operating divisions. The company believes this strategy will help bring them closer to customers and expedite the bedside-to-bench process for developing new products.
Medical Device Business Strategies

CardiAQ Valve Technologies

Today, mitral valve repair and replacement procedures involve opening the chest and stopping the heart. Hence, many patients who might otherwise benefit from therapy are excluded because they are either too ill or not ill enough to justify the risk. A percutaneous mitral valve replacement system in development from CardiAQ Valve Technologies intends to significantly reduce that risk by using a catheter to deliver a new mitral valve.
Medical Device

Percutaneous Heart Valve Technology: The Mitral Challenge

While there is no question that heart valve repair and replacement is moving toward minimally invasive techniques and devices, there is a big difference between a minimally invasive surgical approach and a truly percutaneous, incisionless procedure. The challenges of reaching the latter goal are substantial, but apparently not insurmountable., In fact, recent progress in this field provides hope that in the not too distant future, percutaneous valve replacement and repair will become an accepted part of the treatment armamentarium, greatly expanding the number of patients who can be offered these potentially life-saving procedures.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Viacor Inc.
  • Senior Management
  • Jonathan M Rourke, CEO
    Richard T Spencer, VP, Mktg. & Bus. Dev.
    William T Hayes, Jr., VP, Fin. & Admin.
    David S Marks, MD, Chief Medical Officer
  • Contact Info
  • Viacor Inc.
    Phone: (978) 657-5099
    260-B Fordham Road
    Wilmington, MA 01887
    USA
UsernamePublicRestriction

Register